Newborn Screening Quality Assurance Program for CFTR Mutation Detection and Gene Sequencing to Identify Cystic Fibrosis

Παρόμοια τεκμήρια

• Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study
  ανά: Baker, Mei W., κ.ά.
  Έκδοση: (2015)
• Implementation of the First Worldwide Quality Assurance Program for Cystic Fibrosis Multiple Mutation Detection in Population-Based Screening
  ανά: Earley, Marie C., κ.ά.
  Έκδοση: (2011)
• The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
  ανά: Bergougnoux, Anne, κ.ά.
  Έκδοση: (2020)
• The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality
  ανά: De Jesús, Víctor R., κ.ά.
  Έκδοση: (2015)
• Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
  ανά: Danieli B Salinas, κ.ά.
  Έκδοση: (2016-01-01)